A $3.2 billion deal from GSK, accused of causing cancer with its drug Zantac in the United States
While GSK agrees to pay $3.2 billion to end a series of cases alleging that its heartburn drug Zantac could ...
While GSK agrees to pay $3.2 billion to end a series of cases alleging that its heartburn drug Zantac could ...
Ludwig Cancer Research scientists have developed a comprehensive, start-to-finish computational pipeline that integrates multiple molecular and genetic analyzes of tumors ...
Researchers at the University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung ...
Researchers at the Heart Research Institute (HRI) have made a new discovery: An existing drug used to kill tumor cells ...
A study led by Umeå University, Sweden, presents new insights into how stem cells develop and transform into specialized cells. ...
The survival rate of men with prostate cancer who underwent complete prostate removal immediately after detection of the tumor increased ...
How bladder cancer begins and progresses has been shed light like never before in a study led by researchers at ...
Triple negative breast cancer (TNBC) is the most difficult subtype of breast cancer to treat. TNBC patients account for more ...
In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in the treatment of ...
Since the 1950s, a chemotherapy drug called 5-fluorouracil has been used to treat many types of cancer, including blood cancers ...
© 2023 News by The Manhattan Tribune
© 2023 News by The Manhattan Tribune